Nimodipine liposome for nasal delivery and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TIANJIN UNIV OF TRADITIONAL CHINESE MEDICINE
- Publication Date
- 2015-06-17
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a nimodipine liposome for nasal administration and a preparation method thereof, belonging to the field of pharmaceutical preparations. Background technique
[0002] Nimodipine (Nimodipine, NM) is a dihydropyridine calcium ion antagonist with strong selective expansion of cerebrovascular effect. It has a good therapeutic effect on diseases such as stroke, sudden deafness, and brain dysfunction caused by chronic cerebrovascular disease. However, due to the poor water solubility of NM and the serious first-pass effect, the bioavailability of oral preparations such as tablets and capsules is low, and the average bioavailability is only 5-20%. In order to maintain the curative effect, patients need large doses and frequent medication. This not only increases the toxic and side effects of the drug, but also the concentration of nimodipine transported into the brain after oral administration is easily affected by changes in physiolo...